Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P25
Within normal range
vs 3Y Ago
-2.8x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -66.50% |
| 2024 | -276.18% |
| 2023 | 193.56% |
| 2022 | 23.44% |
| 2021 | 0.00% |